Medication Overuse Headache Clinical Trial
Official title:
Is Detoxification Needed in Medication-overuse Headache?: A Randomized Controlled Trial of 3 Treatment Strategies
Medication-overuse headache (MOH) is a disabling condition, yet treatable. According to
European guidelines and based on evidence, multidisciplinary detoxification is the first
choice of treatment for MOH. However, consensus about the details in such detoxification
programs is lacking. Contrary, other headache specialists believe more in treating chronic
headache with medication overuse with single-therapy of prophylaxis and no withdrawal of
acute medication, based on randomized controlled double-blinded placebo trial with
prophylaxes. Only a single RCT has compared single-therapy with prophylaxis to
detoxification. However there was no significant difference.
AIM:
1. To compare three different treatment protocols in order to improve the therapy of MOH.
2. To test several baseline variables for being potential predictors for good treatment
outcome.
3. To examine the role of epigenetics in MOH.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05720819 -
Biofeedback-VR for Treatment of Chronic Migraine
|
N/A | |
Terminated |
NCT02583425 -
Pilot Study of DFN-11 Injection in Medication Overuse Headache
|
Phase 2 | |
Recruiting |
NCT03655184 -
An Observation Study on Neuropsychology and Serum Melatonin Level in Patients With Medication Overuse Headache
|
||
Active, not recruiting |
NCT05608642 -
Intravenous Treatments Used in Medication Overuse Headache Bridge Treatment
|
N/A | |
Recruiting |
NCT03671681 -
Mindfulness Therapy for Chronic Migraine
|
N/A | |
Completed |
NCT01078012 -
Short Intervention for Medication Overuse Headache (MOH) - Pilot
|
N/A | |
Completed |
NCT03767062 -
Peripheral Nerve Block and Topiramate in the Treatment of Medication Overuse Headaches
|
N/A | |
Recruiting |
NCT01754571 -
CBT in Patients With Medication Overuse Headache
|
Phase 0 | |
Completed |
NCT02435056 -
Medication Overuse Headache (MOH) and an Innovative Approach
|
N/A | |
Recruiting |
NCT05452239 -
A Study of Eptinezumab in Participants With Migraine and Medication Overuse Headache
|
Phase 4 | |
Completed |
NCT01044251 -
Frovatriptan as a Transitional Therapy in Medication Overuse Headache
|
Phase 2 | |
Completed |
NCT00918671 -
Medication-overuse Headache: 4 Years Follow up
|
||
Completed |
NCT04336267 -
Anodal tDCS in Chronic Migraine With Medication Overuse
|
N/A | |
Enrolling by invitation |
NCT01752439 -
Effects of Transcranial Direct Current Stimulation in Refractory Chronic Migraine and Medication-overuse Headache
|
N/A | |
Completed |
NCT00833209 -
Orbitofrontal Cortex (OFC) Influence on Addictive Medication Overuse Headache (MOH) Deriving From Migraine
|
N/A | |
Completed |
NCT04772742 -
Eptinezumab in Adults With Migraine and Medication Overuse Headache
|
Phase 3 | |
Completed |
NCT04228809 -
tDCS in Chronic Migraine With Medication Overuse (Edisom)
|
N/A | |
Not yet recruiting |
NCT05334927 -
China HeadAche DIsorders RegiStry
|
||
Completed |
NCT04090333 -
Endocrinological Profile in Patients With Medication-overuse Headache Before and After Withdrawal Therapy
|
||
Recruiting |
NCT01317992 -
Ibudilast in the Treatment of Medication Overuse Headache
|
Phase 1/Phase 2 |